Cel-Sci
CVM
#9782
Rank
S$64.98 M
Marketcap
S$8.13
Share price
-2.79%
Change (1 day)
-68.43%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -S$32.58 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$34.45 Million, an increase over its 2023 earnings that were of -S$39.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$32.58 Million-5.42%
2024 -S$34.45 Million-12.41%
2023 -S$39.33 Million-12.87%
2022 -S$45.14 Million-3.42%
2021 -S$46.74 Million13.44%
2020 -S$41.2 Million11.28%
2019 -S$37.03 Million179.81%
2018 -S$13.24 Million-48.72%
2017 -S$25.81 Million-16.23%
2016 -S$30.81 Million-23.63%
2015 -S$40.34 Million-5.47%
2014 -S$42.67 Million198.49%
2013 -S$14.3 Million
2010 -S$16.69 Million
2004 -S$5.64 Million12.38%
2003 -S$5.02 Million-16.59%
2002 -S$6.02 Million-59.28%
2001 -S$14.78 Million23.17%
2000 -S$12 Million20.12%
1999 -S$9.99 Million13.24%
1998 -S$8.82 Million-20%
1997 -S$11.03 Million46.55%
1996 -S$7.53 Million34.88%
1995 -S$5.58 Million2.38%
1994 -S$5.45 Million68%
1993 -S$3.25 Million78.57%
1992 -S$1.82 Million180%
1991 -S$0.65 Million25%
1990 -S$0.52 Million-0%
1989 -S$0.52 Million-71.43%
1988 -S$1.82 Million-0%
1987 -S$1.82 Million-46.15%
1986 -S$3.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-S$42.22 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.58 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.68 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-S$0.18 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.29 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$42.00 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.31 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA